AP9500717A0 - Novel method - Google Patents

Novel method

Info

Publication number
AP9500717A0
AP9500717A0 AP9500717A AP9500717A AP9500717A0 AP 9500717 A0 AP9500717 A0 AP 9500717A0 AP 9500717 A AP9500717 A AP 9500717A AP 9500717 A AP9500717 A AP 9500717A AP 9500717 A0 AP9500717 A0 AP 9500717A0
Authority
AP
ARIPO
Prior art keywords
novel method
novel
Prior art date
Application number
AP9500717A
Other versions
AP553A (en
Original Assignee
Smithkine Beecham P L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9402624A external-priority patent/GB9402624D0/en
Priority claimed from GB9410214A external-priority patent/GB9410214D0/en
Priority claimed from GBGB9426019.7A external-priority patent/GB9426019D0/en
Application filed by Smithkine Beecham P L C filed Critical Smithkine Beecham P L C
Publication of AP9500717A0 publication Critical patent/AP9500717A0/en
Application granted granted Critical
Publication of AP553A publication Critical patent/AP553A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
APAP/P/1995/000717A 1994-02-10 1995-02-08 Use of insulin sensitizers for treating renal failure. AP553A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402624A GB9402624D0 (en) 1994-02-10 1994-02-10 Novel method
GB9410214A GB9410214D0 (en) 1994-05-21 1994-05-21 Novel method
GBGB9426019.7A GB9426019D0 (en) 1994-12-22 1994-12-22 Novel method

Publications (2)

Publication Number Publication Date
AP9500717A0 true AP9500717A0 (en) 1995-04-30
AP553A AP553A (en) 1996-11-06

Family

ID=27267046

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1995/000717A AP553A (en) 1994-02-10 1995-02-08 Use of insulin sensitizers for treating renal failure.

Country Status (11)

Country Link
EP (1) EP0777469A1 (en)
JP (1) JPH09512249A (en)
CN (2) CN1083715C (en)
AP (1) AP553A (en)
AU (1) AU700826B2 (en)
CA (1) CA2182986A1 (en)
IL (1) IL112590A (en)
MX (1) MX9603338A (en)
SG (1) SG47100A1 (en)
TW (1) TW475896B (en)
WO (1) WO1995021608A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (en) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidinedione derivatives, process of their preparation, pharmaceutical compositions in which the derivatives are comprised and their use in the treatment of diabetes mellitus and related diseases
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6011036A (en) * 1997-04-15 2000-01-04 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
CN1208335C (en) 1999-04-23 2005-06-29 史密丝克莱恩比彻姆有限公司 Thiazolidinedione derivative and its use as antidiabetic
AU7408900A (en) * 1999-08-17 2001-03-13 Smithkline Beecham Plc Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
WO2001090356A1 (en) * 2000-05-25 2001-11-29 Yamanouchi Pharmaceutical Co., Ltd. Human pgc-1 promoter
GB0019223D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
WO2006096398A2 (en) 2005-03-03 2006-09-14 Smithkline Beecham Corporation Medicaments
US20100099640A1 (en) 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
FR2680512B1 (en) * 1991-08-20 1995-01-20 Adir NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPH05310719A (en) * 1992-04-28 1993-11-22 Terumo Corp Thiazolidine-2,4-dione derivative

Also Published As

Publication number Publication date
SG47100A1 (en) 1998-03-20
WO1995021608A1 (en) 1995-08-17
AP553A (en) 1996-11-06
TW475896B (en) 2002-02-11
AU700826B2 (en) 1999-01-14
IL112590A (en) 2002-08-14
CN1145027A (en) 1997-03-12
EP0777469A1 (en) 1997-06-11
CA2182986A1 (en) 1995-08-17
IL112590A0 (en) 1995-06-29
MX9603338A (en) 1997-03-29
CN1318372A (en) 2001-10-24
JPH09512249A (en) 1997-12-09
CN1083715C (en) 2002-05-01
AU1578395A (en) 1995-08-29

Similar Documents

Publication Publication Date Title
GB9600464D0 (en) Novel method
GB9521447D0 (en) Method
AP9500717A0 (en) Novel method
GB2289946B (en) Method
GB9417135D0 (en) Method
GB9414624D0 (en) Novel method
GB9415073D0 (en) Novel method
GB9423905D0 (en) Novel method
GB9609722D0 (en) Novel method
GB9604465D0 (en) Novel method
GB9424723D0 (en) Method
GB9401566D0 (en) Method
ZA951002B (en) Novel method
GB9421473D0 (en) Novel method
GB9406789D0 (en) Novel method
GB9402623D0 (en) Novel method
GB9410214D0 (en) Novel method
GB9426019D0 (en) Novel method
GB9414770D0 (en) Method
GB9417136D0 (en) Method
GB9421234D0 (en) Method
GB9402414D0 (en) Method
GB9412320D0 (en) Method
GB9401106D0 (en) Method
GB9403193D0 (en) Method